Maxigen Biotech Inc
TWSE:1783

Watchlist Manager
Maxigen Biotech Inc Logo
Maxigen Biotech Inc
TWSE:1783
Watchlist
Price: 41.9 TWD 0.12% Market Closed
Market Cap: 3.7B TWD
Have any thoughts about
Maxigen Biotech Inc?
Write Note

Maxigen Biotech Inc
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Maxigen Biotech Inc
Accounts Payable Peer Comparison

Comparables:
G
1707
1731
4137

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Maxigen Biotech Inc
TWSE:1783
Accounts Payable
NT$33.2m
CAGR 3-Years
-9%
CAGR 5-Years
-3%
CAGR 10-Years
3%
G
Grape King Bio Ltd
TWSE:1707
Accounts Payable
NT$389.4m
CAGR 3-Years
3%
CAGR 5-Years
10%
CAGR 10-Years
14%
Maywufa Co Ltd
TWSE:1731
Accounts Payable
NT$84.7m
CAGR 3-Years
-12%
CAGR 5-Years
-29%
CAGR 10-Years
-15%
Chlitina Holding Ltd
TWSE:4137
Accounts Payable
NT$112.3m
CAGR 3-Years
-4%
CAGR 5-Years
14%
CAGR 10-Years
5%

See Also

What is Maxigen Biotech Inc's Accounts Payable?
Accounts Payable
33.2m TWD

Based on the financial report for Jun 30, 2024, Maxigen Biotech Inc's Accounts Payable amounts to 33.2m TWD.

What is Maxigen Biotech Inc's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
3%

Over the last year, the Accounts Payable growth was 59%. The average annual Accounts Payable growth rates for Maxigen Biotech Inc have been -9% over the past three years , -3% over the past five years , and 3% over the past ten years .

Back to Top